Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15363126rdf:typepubmed:Citationlld:pubmed
pubmed-article:15363126lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C1512310lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0376515lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C1332823lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0001515lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0382569lld:lifeskim
pubmed-article:15363126lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:15363126pubmed:issue4lld:pubmed
pubmed-article:15363126pubmed:dateCreated2004-9-14lld:pubmed
pubmed-article:15363126pubmed:abstractTextTo study the importance of chemokine SDF-1 in surviving of acute myelocytic leukemia cells HL-60, the adhesion ability of HL-60 and expression of Bcl-2, Fas protein when SDF-1 activity was blocked by anti-CXCR4 monoclonal antibody (12G5) were compared with those detected before MAb incubation, in this experiment, HL-60 cell were cultured and co-cultured with normal marrow stromal cell. The adhesion rate was detected while the expression of Bcl-2 and Fas proteins were assayed by immunohistochemical technique when SDF-1 activity was inhibited. The results showed that cell adhesion rate of HL-60 decreased while the expression Bcl-2 decreased and Fas increased. It is concluded that inhibition of SDF-1 activity increases cell apoptosis and thus reduces life-span of leukemia cell at certain level.lld:pubmed
pubmed-article:15363126pubmed:languagechilld:pubmed
pubmed-article:15363126pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:citationSubsetIMlld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15363126pubmed:statusMEDLINElld:pubmed
pubmed-article:15363126pubmed:monthAuglld:pubmed
pubmed-article:15363126pubmed:issn1009-2137lld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:FuY PYPlld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:AHHlld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:HongLiuLlld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:ZhangYiYlld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:ChengChangClld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:KongPei-YanPYlld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:ChenXing-HuaX...lld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:PengXian-GuiX...lld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:ZengDong-Feng...lld:pubmed
pubmed-article:15363126pubmed:authorpubmed-author:WangQing-YuQYlld:pubmed
pubmed-article:15363126pubmed:issnTypePrintlld:pubmed
pubmed-article:15363126pubmed:volume12lld:pubmed
pubmed-article:15363126pubmed:ownerNLMlld:pubmed
pubmed-article:15363126pubmed:authorsCompleteYlld:pubmed
pubmed-article:15363126pubmed:pagination436-40lld:pubmed
pubmed-article:15363126pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:meshHeadingpubmed-meshheading:15363126...lld:pubmed
pubmed-article:15363126pubmed:year2004lld:pubmed
pubmed-article:15363126pubmed:articleTitle[Effects of anti- CXCR4 monoclonal antibody on adhesiveness of human acute myelocytic leukemia cell line HL-60 and expression of Bcl-2, Fas proteins].lld:pubmed
pubmed-article:15363126pubmed:affiliationDepartment of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing 400037, China.lld:pubmed
pubmed-article:15363126pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15363126pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:15363126pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed